AstraZeneca PLC
22 August 2006
Companies Act 1985 Section 198
Disclosure of Interest in Voting Shares in Public Companies
On 22 August 2006 we were informed by Barclays PLC, that on 16 August 2006 its
interest in the USD0.25 Ordinary Shares of AstraZeneca PLC had decreased to
60,890,928 shares (3.90 per cent of the current issued ordinary capital) from
the previously notified level of 71,754,726 shares (4.60 per cent of the issued
ordinary capital at that time).
G H R Musker
Company Secretary
22 August 2006
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.